CN105267303A - Traditional Chinese medicine composition used for protecting livers - Google Patents

Traditional Chinese medicine composition used for protecting livers Download PDF

Info

Publication number
CN105267303A
CN105267303A CN201510846515.8A CN201510846515A CN105267303A CN 105267303 A CN105267303 A CN 105267303A CN 201510846515 A CN201510846515 A CN 201510846515A CN 105267303 A CN105267303 A CN 105267303A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
traditional chinese
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510846515.8A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510846515.8A priority Critical patent/CN105267303A/en
Publication of CN105267303A publication Critical patent/CN105267303A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition used for protecting livers. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 20-30 parts of radix bupleuri, 20-30 parts of Chinese magnoliavine fruit, 20-40 parts of Szechuan lovage rhizome, 10-20 parts of radix notoginseng and 20-40 parts of virgate wormwood herb. The traditional Chinese medicine composition has the function of protecting livers and does not have obvious toxic or side effect.

Description

A kind of Chinese medicine composition for hepatoprotective
Technical field
The invention belongs to biomedicine field, be specifically related to a kind of Chinese medicine composition for hepatoprotective.
Background technology
Liver is the important metabolic organ of body, and it all plays an important role in the substance metabolismes such as sugar, lipid, protein, vitamin, hormone, bile pigments, and liver also has the function of the aspects such as secretion, excretion, biological conversion simultaneously.Containing abundant enzyme in hepatocyte, and synthesize many enzymes and various thrombin, store and release Hemopoietic factor, participate in blood coagulation and hematopoiesis.Liver is also the barrier organ of body, and its removing toxic substances and phagocytic function have important protective effect to body.The then dysbolismus when liver function damage is hindered, and affect other organs function, seriously then threat to life.Liver has Hepatic artery and pylic double blood supply, and has a large amount of blood sinus, and directly and contacting blood, the permeability of liver plasma membrane is comparatively large simultaneously, therefore often carries out active effective mass exchange between hepatocyte and blood for liver plasma membrane.
Virus, medicine and noxious substance, autoimmune hepatitis etc. all can cause hepatic necrosis.Research shows, when remaining liver cell regeneration in hepatic necrosis, then often with liver interstitial proliferation, namely causes hepatic fibrosis and liver cirrhosis.When liver cirrhosis, venous blood flow is obstructed, and causes hepatic vein and portal hypertension, promotes the formation that in liver, arteriovenous anastomosis is propped up, causes hepatocyte blood supply to reduce, and then hepatocellular degeneration and necrosis occurs, fibroplasia, and liver cirrhosis is more serious, causes vicious cycle.When liver major injury, compensatory capacity significantly weakens, then occur serious hepatic insufficiency, be further development of hepatic failure, and and then cause central nervous system dysfunction, there is hepatic coma.Various injurious factor and material, as virus, medicine, ethanol etc. all can excite hepatocyte to damage, and produce a series of medium, cause hepatic necrosis, inflammation, Fibrotic pathological process, finally cause various hepatic disease.
Research finds that Cordyceps has liver-protective effect, can prevent hepatocyte spotty necrosis and focal necrosis.The Radix Astragali can make rat liver fibrosis degree obviously reduce, and reduces total collagen I, the deposition of III, IV Collagen Type VI in liver.Radix Salviae Miltiorrhizae is a kind of up-and-coming anti-liver injury Chinese medicine, and its mechanism of action is many-sided, and as improved microcirculation in liver, anti-lipid peroxidation, protection hepatocyte, promotes the collagen degradation of deposition and heavily absorb.Radix Notoginseng has effect of activating blood circulation to dissipate blood stasis, can suppress the activity of fibroblast and Ito cell in liver, reduces the generation of collagen fiber.In addition, the anti-liver injury of the Chinese medicine such as Radix Glycyrrhizae, Poria, Fructus Schisandrae Chinensis, Radix Bupleuri, Flos Carthami, Herba Sedi, Herba Silybi mariani acts in experimentation and have also been obtained confirmation.
Summary of the invention
Comprehensive state of the art and Problems existing, the object of the present invention is to provide a kind of Chinese medicine composition for hepatoprotective, the present invention is pure Chinese medicinal preparation, has the effect of hepatoprotective, without obvious toxic-side effects.
For achieving the above object, the present invention is made up of the raw material of following masses ratio: Radix Bupleuri 20-30 part, Fructus Schisandrae Chinensis 20-30 part, Rhizoma Chuanxiong 20-40 part, Radix Notoginseng 10-20 part, Herba Artemisiae Scopariae 20-40 part.Form of administration preferred oral preparation of the present invention.
Detailed description of the invention
Embodiment 1. the present invention be made up of the raw material of following masses ratio: Radix Bupleuri 20 parts, Fructus Schisandrae Chinensis 30 parts, Rhizoma Chuanxiong 40 parts, Radix Notoginseng 10 parts, Herba Artemisiae Scopariae 40 parts.
Embodiment 2. the present invention be made up of the raw material of following masses ratio: Radix Bupleuri 30 parts, Fructus Schisandrae Chinensis 20 parts, Rhizoma Chuanxiong 20 parts, Radix Notoginseng 20 parts, Herba Artemisiae Scopariae 20 parts.

Claims (1)

1. for a Chinese medicine composition for hepatoprotective, be made up of the raw material of following masses ratio: Radix Bupleuri 20-30 part, Fructus Schisandrae Chinensis 20-30 part, Rhizoma Chuanxiong 20-40 part, Radix Notoginseng 10-20 part, Herba Artemisiae Scopariae 20-40 part.
CN201510846515.8A 2015-11-28 2015-11-28 Traditional Chinese medicine composition used for protecting livers Pending CN105267303A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510846515.8A CN105267303A (en) 2015-11-28 2015-11-28 Traditional Chinese medicine composition used for protecting livers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510846515.8A CN105267303A (en) 2015-11-28 2015-11-28 Traditional Chinese medicine composition used for protecting livers

Publications (1)

Publication Number Publication Date
CN105267303A true CN105267303A (en) 2016-01-27

Family

ID=55137700

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510846515.8A Pending CN105267303A (en) 2015-11-28 2015-11-28 Traditional Chinese medicine composition used for protecting livers

Country Status (1)

Country Link
CN (1) CN105267303A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107095996A (en) * 2016-02-22 2017-08-29 杨金禄 A kind of Chinese medicine hepatoprotective composition
CN107753818A (en) * 2017-11-28 2018-03-06 李习军 A kind of Chinese medicine for treating hepatopathy

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1457854A (en) * 2003-05-17 2003-11-26 杨涛 Health pill for liver
CN1559493A (en) * 2004-02-22 2005-01-05 通化方大药业股份有限公司 Medicine for treating hapatitis
CN1843431A (en) * 2006-02-22 2006-10-11 山东润华药业有限公司 Medicine for treating hepatitis and its preparing process
CN101385778A (en) * 2007-09-14 2009-03-18 通化方大药业股份有限公司 Ganjiaxin tablet
CN101496880A (en) * 2008-01-28 2009-08-05 天科仁祥技术(北京)有限责任公司 Chinese medicinal composition for protecting liver and preparation method thereof
CN102512500A (en) * 2012-01-10 2012-06-27 天圣制药集团股份有限公司 Preparation for treating chronic hepatitis and cirrhosis and preparation method of preparation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1457854A (en) * 2003-05-17 2003-11-26 杨涛 Health pill for liver
CN1559493A (en) * 2004-02-22 2005-01-05 通化方大药业股份有限公司 Medicine for treating hapatitis
CN1843431A (en) * 2006-02-22 2006-10-11 山东润华药业有限公司 Medicine for treating hepatitis and its preparing process
CN101385778A (en) * 2007-09-14 2009-03-18 通化方大药业股份有限公司 Ganjiaxin tablet
CN101496880A (en) * 2008-01-28 2009-08-05 天科仁祥技术(北京)有限责任公司 Chinese medicinal composition for protecting liver and preparation method thereof
CN102512500A (en) * 2012-01-10 2012-06-27 天圣制药集团股份有限公司 Preparation for treating chronic hepatitis and cirrhosis and preparation method of preparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
董明慧等: "具有保肝作用的临床常用中药", 《中医药导报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107095996A (en) * 2016-02-22 2017-08-29 杨金禄 A kind of Chinese medicine hepatoprotective composition
CN107753818A (en) * 2017-11-28 2018-03-06 李习军 A kind of Chinese medicine for treating hepatopathy

Similar Documents

Publication Publication Date Title
US6455078B1 (en) Medicinal herbal composition for treating liver diseases and HIV
CN105213410A (en) Anemoside B4 is as the application of immunomodulator in treatment acute inflammation medicine
CA2685684C (en) Use of a botanical composition in preparing pharmaceutical preparation for treatment of cirrhotic portal hypertension
CN105168142A (en) Preparation method and application of stem type traditional Chinese medicinal material granules
CN105267303A (en) Traditional Chinese medicine composition used for protecting livers
CN105497515B (en) A kind of two ginseng composition of smart stilbene with oxygen lack resistant function
CN1593472A (en) Pharmaceutical composition for treating liver diseases and its application
CN105395678A (en) Liver protection medicine
CN105125408A (en) Preparation method and application of rhizome traditional Chinese medicinal material decocting-free preparation
CN105311208A (en) Traditional Chinese medicine composition used for protecting livers
CN105250361A (en) Traditional Chinese medicine composition capable of protecting liver
CN104587161A (en) Traditional Chinese medicine composition for treating nephropathy of amylaidosis
CN105267272A (en) Traditional Chinese medicine used for protecting livers
CN105267887A (en) Liver protecting medicine composition
CN105250473A (en) Traditional Chinese medicine composition for protecting liver
CN105311577A (en) Traditional Chinese medicine for protecting liver
CN105362447A (en) Traditional Chinese medicine composition with function of liver protection
CN105311154A (en) Traditional Chinese medicine composition and application
CN105287855A (en) Liver-protection traditional Chinese medicine composition
CN105287856A (en) Liver protection medicine
CN104435977A (en) Medicine for treating liver injuries and preparation method of medicine
CN104666544A (en) Traditional Chinese medicine for treating hepatitis
CN113577179A (en) Pharmaceutical composition for liver injury protection and application thereof
CN103239674B (en) Antineoplastic traditional Chinese medicine composition and preparation method thereof
CN1319578C (en) Prescription of Chinese medicine compound preparation, its preparation method and use

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160127

WD01 Invention patent application deemed withdrawn after publication